These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 4876157

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Evaluation of the effect of nalidixic acid on experimental E. coli ascendent or hematogenous pyelonephritis].
    Prát V, Konícková L, Hatala M, Urbanová D.
    Cas Lek Cesk; 1968 Dec 06; 107(50):1515-20. PubMed ID: 4885857
    [No Abstract] [Full Text] [Related]

  • 5. Piromidic acid and beta-hydroxypiromidic acid: therapeutic effectiveness on experimental E. coli pyelonephritis in the rat.
    Loew H, Ritzerfeld W.
    Int J Clin Pharmacol; 1973 Apr 06; 7(2):234-7. PubMed ID: 4581342
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Experience with nalidixic acid in pyelonephritis in children].
    Zapp E.
    Arch Kinderheilkd; 1968 Apr 06; 177(1):53-60. PubMed ID: 4880029
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of chloramphenicol against different E. coli strains in vitro and in experimental pyelonephritis].
    Prát V, Konícková L, Ritzerfeld W, Losse H.
    Arzneimittelforschung; 1968 Sep 06; 18(9):1123-7. PubMed ID: 4885372
    [No Abstract] [Full Text] [Related]

  • 9. [Sensitivity of an E. coli strain during therapy of experimental pyelonephritis using nalidixic acid].
    Hatala M, Ritzerfeld W, Prát V, Konícková L, Losse H.
    Cas Lek Cesk; 1970 Mar 06; 109(14):291-6. PubMed ID: 4909024
    [No Abstract] [Full Text] [Related]

  • 10. Nalidixic acid in urinary tract infections with particular reference to the emergence of resistance.
    Cederberg A, Denneberg T, Ekberg M, Juhlin I.
    Scand J Infect Dis; 1974 Mar 06; 6(3):259-64. PubMed ID: 4607842
    [No Abstract] [Full Text] [Related]

  • 11. [Therapy of experimental ascending E. coli pyelonephritis with anlidixic acid].
    Konícková L, Prát V, Hatala M, Urbanová D.
    Rozhl Chir; 1968 Nov 06; 47(10):745-50. PubMed ID: 4883721
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Experimental pyelonephritis, chemotherapeutic studies (review of the literature)].
    Rudzit EA, Lisitsa LI.
    Farmakol Toksikol; 1971 Nov 06; 34(2):246-50. PubMed ID: 4998195
    [No Abstract] [Full Text] [Related]

  • 16. [Some bacteriological and clinical aspects of the treatment or chronic pyelonephritis with Negram].
    Liwski R, Gietko G.
    Pol Arch Med Wewn; 1969 May 06; 42(5):759-66. PubMed ID: 4894225
    [No Abstract] [Full Text] [Related]

  • 17. Are quinolone-resistant uropathogenic Escherichia coli less virulent?
    Vila J, Simon K, Ruiz J, Horcajada JP, Velasco M, Barranco M, Moreno A, Mensa J.
    J Infect Dis; 2002 Oct 01; 186(7):1039-42. PubMed ID: 12232848
    [Abstract] [Full Text] [Related]

  • 18. Nalidixic acid in urinary infection.
    Neogy KN, De MS, Chatterjee ML.
    Bull Calcutta Sch Trop Med; 1968 Jan 01; 16(1):11-2. PubMed ID: 4890385
    [No Abstract] [Full Text] [Related]

  • 19. [Antibacterial effect of two sulfonamide compoundds in acute experimental E. coli-pyelonephritis].
    Konicková L, Prát V, Ritzerfeld W, Losse H.
    Arzneimittelforschung; 1969 Oct 01; 19(10):1717-20. PubMed ID: 4902491
    [No Abstract] [Full Text] [Related]

  • 20. Activity of tetracyclines, nalidixic acids, and nitrofurantoin in two experimental models of Escherichia coli urinary tract disease in rats.
    English AR.
    Proc Soc Exp Biol Med; 1971 Apr 01; 136(4):1094-6. PubMed ID: 4928932
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.